Log in or Sign up for Free to view tailored content for your specialty!
Alzheimer’s Disease/Dementia News
Herpes simplex virus 1 may be associated with increased risk for Alzheimer's, dementia
Mounting evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease and dementia, according to a systematic review of published studies.
Quantification of amyloid PET scans feasible, consistent with visual analysis in AD
For clinicians who treat patients with Alzheimer’s disease, quantification of amyloid positron emission tomography was feasible and possessed a high degree of concordance with visual analysis, according to a presentation at CTAD.
Log in or Sign up for Free to view tailored content for your specialty!
Technology use highly accepted by caregivers, those with AD-related agitation
Technology was found to be both easy to use and highly acceptable in a cohort of those with Alzheimer’s-related agitation and their caregivers, according to a poster presentation at CTAD.
Customized transcription linked to more accurate speech-based AD screening
A customized speech transcription model logged roughly 30% fewer errors compared with manual or automated methods and may be a more effective tool in assessing verbal Alzheimer’s disease-related impairment.
Computerized training improved cognitive performance in those with MCI
Individuals with mild cognitive impairment performed faster on functional skills assessments and logged fewer dropouts when undergoing concurrent burst cognitive training, according to a poster from CTAD.
Participation in digital cognitive test, biomarker assays linked to AD study enrollment
Participation in memory-based digital cognitive testing and blood-based biomarker assays for Alzheimer’s-related pathology was linked to successful enrollment into clinical trials for disease-modifying treatment, according to research.
FDA grants orphan drug designation to oral Huntington’s disease therapy
The FDA has granted orphan drug designation to an investigational oral therapeutic for the treatment of Huntington’s disease, according to the manufacturer.
Glial fibrillary acidic protein may identify risk for brain atrophy, cognitive decline
For individuals exposed to athletic-related head contact, glial fibrillary acidic protein may help identify those who are at risk for progressive regional brain atrophy and cognitive decline, per data from Alzheimer’s Research & Therapy.
Longer sleep duration linked to lower brain volume in Hispanic/Latino population
In a diverse cohort of Hispanic/Latino individuals, longer sleep duration was associated with lower total brain and gray matter volume, according to research published in Alzheimer’s & Dementia.
High or low HDL tied to slightly elevated risk for dementia
Older adults with high levels or low levels of HDL had a small increased risk for dementia compared with those with average levels, researchers reported in Neurology.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read